Skip to content

Cervical-Cranial Dry Needling vs. Orthopedic Manual Therapy for Cervicogenic Headache

Comparing the Use of Cervical-Cranial Dry Needling With Orthopedic Manual Therapy to the Cervical Spine for Cervicogenic Headache: A Multi-center RCT With 1-Year Follow Up

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03583190
Enrollment
100
Registered
2018-07-11
Start date
2018-07-05
Completion date
2025-12-10
Last updated
2023-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervicogenic Headache

Keywords

Neck pain, Headache, Dry needling, manual therapy

Brief summary

Dry needling is a therapeutic modality used to treat a number of neuromusculoskeletal conditions. Practice trends suggest it is becoming widely used by Physical Therapists to help patients manage symptoms associated with CGH, however, there is limited scientific evidence demonstrating meaningful impact for dry needling for CGH. Manual therapy (thrust and non-thrust mobilizations) to the cervical spine are well researched and have an established treatment effect for managing symptoms related to CGH. The purpose of this study is to compare outcomes (1 week, 1 month, 3 months, 12 months) for patients with CGH treated with cervical-cranial dry needling or pragmatically applied orthopedic manual therapy to the cervical spine. In addition to either the cervical-cranial dry needling or manual therapy to the cervical spine, patients will also receive patient education, thoracic manipulation, and exercise.

Detailed description

The use of dry needling is becoming widely used by Physical Therapists in the United States for a number of neuromusculoskeletal conditions including cervicogenic headache (CGH). Dry needling is performed by taking a mono-filament needle and inserting it into symptomatic soft tissue. In this trial, the dry needling will be performed segmentally in the neck and along the patient's headache distribution pattern. Orthopedic manual therapy (OMT) may include both thrust and non-thrust techniques applied to a targeted spinal level and has a well-established treatment effect for patients with CGH. In this trial, the OMT will be applied pragmatically to the cervical spine at the most symptomatic level of the headache. Other interventions used in this trial will include patient education, thoracic manipulation and exercise. Patients will be randomized to receive either dry needling or OMT 2x/week for 2 weeks and then 1-2x/week for 2 weeks totaling 6-8 visits over the course of 1 month. The 1 week and 1 month outcomes collected will be reported on separately from the 3 and 12 months.

Interventions

OTHERCervical-cranial dry needling

Segmental needling of the neck and needling in the patient's headache distribution. Peripherally sensitized areas of the neck may also be dry needled based on the findings of the clinical evaluation.

Orthopedic Manual Therapy (OMT) that includes either mobilization or manipulation to the cervical spine applied pragmatically to the most symptomatic level.

Thoracic Manipulation (applied pragmatically) to the levels determined to be provocative or hypomobile.

OTHERExercise

Clinicians select 1 active range of motion exercise for the cervical spine, deep cervical flexion endurance exercise, and 5 upper extremity exercises (from a set of 10). Additionally, patients will be assigned a headache management technique.

OTHERPatient Education

Patients will receive education regarding their headache condition, proper performance of their symptom management technique, posture.

Sponsors

Franklin Pierce University
CollaboratorOTHER
Youngstown State University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Caregiver, Outcomes Assessor)

Masking description

The outcome assessor will be blinded the treatment group. The clinician providing treatment will be blinded to outcomes.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years or older * Meets the IHS criteria for CGH * Headache frequency of at least 1 per week over a period greater than 3 months. * Demonstrates segmental dysfunction with passive mobility testing.

Exclusion criteria

Patients whose headache experience is primarily of migraine origin. Tension-type headache, headache pain \<2, contraindications to the interventions (malignancy, myelopathy, fracture, metabolic disease, rheumatoid arthritis, long-term corticosteroid use), headache presentation suggesting cervical arterial insufficiency, severe metal allergy, needle phobia, history of neck or thoracic spine surgery, Non-English speaking patients, therapist is unable to elicit the headache with passive accessory intervertebral movements (PAIVM), or pending litigation for neck pain and/or headache.

Design outcomes

Primary

MeasureTime frameDescription
Change in NPRS headache intensityBaseline, 1 week, 1 month, 3 months, 12 months.Average and most intense in the last week will be recorded using a 0 (no headache) to 10 (most intense)

Secondary

MeasureTime frameDescription
Change in disability using Headache Disability Index (HDI)Baseline, 1 week, 1 month, 3 months, 12 monthsThe HDI assesses the burden of chronic headaches, using 25 items that ask about the perceived impact of headaches on emotional functioning and daily activities. Items were designed specifically to assess the concerns of individuals with recurrent headache disorders.
Leeds Assessment of Neuropathic Signs and Symptoms (LANSS)BaselineSubjects identifying particular qualities about their pain (yes/no) that could suggest problems with how the nervous system is interpreting pain. There is a physical screening procedure involving a discriminate evaluation of different sensations (light touch, and sharp/dull) in an area of the subject's body (arm or leg) without pain compared to an area of their pain (neck or head). The questions and results from the physical testing are scored which can range from 0-24.
Change in Medication intakeBaseline, 1 week, 1 month, 3 months, 12 monthsPatients will identify the medications + dosage they have consumed to treat their headache in the past week.
Change in disability using Neck Disability IndexBaseline 1 week, 1 month, 3 months, 12 monthsThe NDI is a self-report measure of perceived disability comprised of ten questions using an ordinal scale from 0 to 5 for a maximum of 50 points.
Health care utilization3 and 12 monthsHealthcare utilization will be reported by subjects identifying on a form any provider they have seen for care of their headaches, treatments they have received, and cost for their headaches.
SANE Percent Recovery1 monthPercent recovery will be measured using a global percentage of improvement is a measure of the patient's perception of the change in their condition.
Change in current NPRS neck or headache intensityBaseline and Immediately post interventionCurrent level of headache or neck pain on a scale ranging from 0 (no headache) to 10 (most intense)
Patient Satisfaction1 monthPatient satisfaction will be assessed using the Patient Satisfaction Instrument (PSI) that measures several constructs related to clinical outcomes and patient care. The PSI consists of 12 questions rated using a scale, 1 (strongly disagree) to 5 (strongly agree).

Countries

United States

Contacts

Primary ContactDavid Griswold, PhD
dwgriswold@ysu.edu330-941-2419

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026